Abstract

A fraction of patients referred for tumor-only complex molecular profiling may harbor germline variants in genes associated with the development of hereditary cancer syndromes (HCS). Bioinformatic management and reporting of such incidental germline findings are not standardized.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call